These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 7565683)
41. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells. Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676 [TBL] [Abstract][Full Text] [Related]
42. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. Manna SK; Aggarwal BB J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347 [TBL] [Abstract][Full Text] [Related]
43. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells. Lee M; Jeon YJ Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860 [TBL] [Abstract][Full Text] [Related]
44. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. Mukhopadhyay A; Manna SK; Aggarwal BB J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693 [TBL] [Abstract][Full Text] [Related]
45. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. Zhou YQ; Chen YQ; Fisher JH; Wang MH J Biol Chem; 2002 Oct; 277(41):38104-10. PubMed ID: 12177064 [TBL] [Abstract][Full Text] [Related]
46. Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. Bomsztyk K; Rooney JW; Iwasaki T; Rachie NA; Dower SK; Sibley CH Cell Regul; 1991 Apr; 2(4):329-35. PubMed ID: 2059661 [TBL] [Abstract][Full Text] [Related]
47. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080 [TBL] [Abstract][Full Text] [Related]
48. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. Shishodia S; Koul D; Aggarwal BB J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936 [TBL] [Abstract][Full Text] [Related]
49. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. Haller D; Russo MP; Sartor RB; Jobin C J Biol Chem; 2002 Oct; 277(41):38168-78. PubMed ID: 12140289 [TBL] [Abstract][Full Text] [Related]
50. A new structural class of proteasome inhibitors that prevent NF-kappa B activation. Lum RT; Kerwar SS; Meyer SM; Nelson MG; Schow SR; Shiffman D; Wick MM; Joly A Biochem Pharmacol; 1998 May; 55(9):1391-7. PubMed ID: 10076530 [TBL] [Abstract][Full Text] [Related]
51. Molecular determinants of NF-kappaB-inducing kinase action. Lin X; Mu Y; Cunningham ET; Marcu KB; Geleziunas R; Greene WC Mol Cell Biol; 1998 Oct; 18(10):5899-907. PubMed ID: 9742107 [TBL] [Abstract][Full Text] [Related]
52. Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB. MacKichan ML; Logeat F; Israël A J Biol Chem; 1996 Mar; 271(11):6084-91. PubMed ID: 8626394 [TBL] [Abstract][Full Text] [Related]
53. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Brockman JA; Scherer DC; McKinsey TA; Hall SM; Qi X; Lee WY; Ballard DW Mol Cell Biol; 1995 May; 15(5):2809-18. PubMed ID: 7739562 [TBL] [Abstract][Full Text] [Related]
54. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Li N; Karin M Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13012-7. PubMed ID: 9789032 [TBL] [Abstract][Full Text] [Related]
55. Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites. Zhang Y; Sun X; Muraoka K; Ikeda A; Miyamoto S; Shimizu H; Yoshioka K; Yamamoto K J Biol Chem; 1999 Dec; 274(49):34657-62. PubMed ID: 10574930 [TBL] [Abstract][Full Text] [Related]
56. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells. Vertegaal AC; Kuiperij HB; Yamaoka S; Courtois G; van der Eb AJ; Zantema A Cell Signal; 2000 Dec; 12(11-12):759-68. PubMed ID: 11152962 [TBL] [Abstract][Full Text] [Related]